€3M to bring AI analytics and advanced data infrastructure to clinical trials

Rivia’s AI-driven data platform addresses the critical inefficiencies in the current clinical trial process, providing a real-time, integrated view of trial data to accelerate the path to market for new therapies. The company has secured a €3M Seed funding round led by Speedinvest.
Zum Beitrag auf Startupticker